-+ 0.00%
-+ 0.00%
-+ 0.00%

Eledon Pharmaceuticals announces annual shareholder meeting

PUBT·04/21/2026 10:01:50
Listen to the news
Eledon Pharmaceuticals announces annual shareholder meeting
  • Eledon Pharmaceuticals scheduled annual stockholders meeting for June 18, 2026 in Irvine, California.
  • Shareholders to vote on election of Class III directors David-Alexandre C. Gros, Jan Hillson, James Robinson to terms ending at 2029 annual meeting.
  • Ballot includes charter amendment to raise authorized common stock to 450,000,000 shares from 300,000,000.
  • Meeting also seeks ratification of Deloitte & Touche as independent registered public accounting firm for year ending Dec. 31, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eledon Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-164367), on April 21, 2026, and is solely responsible for the information contained therein.